Taxane和anthracycline根据当地先进的乳腺癌的neoadjuvant化疗:协会经验。 翻译结果5复制译文编辑译文朗读译文返回顶部 Taxane 和 anthracycline 设立本地被推进的乳腺癌的新辅佐的化疗:制度上的经验。 相关内容 apleas check internet connction settings inyour phnoe and testart application 请求检查互联网connction设置in...
Weekly taxane-anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer:a randomized controlled trial[J]. Qiu-Wen Tan,Ting Luo,Hong Zheng,Ting-Lun Tian,Ping He,Jie Chen,He-Lin Zeng,Qing Lv.Chinese Journal of Cancer. 2017(...
Cisplatin plus gemcitabine chemotherapy in taxane/anthracycline-resistant metastatic breast cancer. Chemo- therapy. 2009;55(3):155-60.Somali I,Alacacioglu A,Tarhan MO,et al.Cisplatin plus gemcitabinechemotherapy in taxane/anthracycline-resistant metastatic breast canc-er. Journal of Chemotherapy . ...
Survival data of patients with anthracycline-or taxane-pretreated or resistant metastatic breast cancer[J].Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy,2009,(12):1482-1490.Barnett CM.Survival data of patients with anthracycline or taxane-pretreated or resistant metastatic breast ...
Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy:... To determine the tolerability and efficacy of the combination of gefitinib with gemcitabine plus vinorelbine in metastatic breast cancer (MBC) ...
A chi-square test was used to compare the incidence and relative risk of short side effects with both anthracycline and taxane-containing regimens. Results The average age of participants was 49.1 years. In both regimens, the findings highlighted the frequency and relative risk of the following ...
Correction: Dual Blockade with AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients with Locally Advanced or Operable Breast Cancer Receiving Taxane-Anthracycline Containing Chemotherapy-DAFNE (GBG-70)... C Hanusch,A Schneeweiss,S Loibl,... - 《Clinical Cancer Research An Official Journal of...
Prolonged Disease Control in a Patient With Anthracycline- and Taxane-Resistant Breast Cancer 来自 掌桥科研 喜欢 0 阅读量: 46 作者:CA Castaneda,HL Gómez 摘要: Resistance to chemotherapy is a complex and very frequent problem in the treatment of breast cancer. It is associated with a poor ...
We aimed to better characterise the benefits and risks of including anthracycline, and the comparative benefits of different anthracycline–taxane regimens. 背景 与不化疗相比,用于早期乳腺癌的蒽环类-紫杉烷类化疗显着提高了生存率。 然而,由于对蒽环类药物的短期和长期副作用的担忧,导致越来越多地使用不含...
This study was aimed to establish clinical efficacy and tolerability of gemcitabine and cisplatin combination in patients with metastatic triple negative breast cancer progressing after anthracycline and taxane based chemotherapies.Thirty-three patients who were given cisplatin and gemcitabine for triple negati...